Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

Abstract

Background:

Patients with psoriasis of all severities employ topical treatment, either alone or in combination. Promoting Patient Engagement at the Leading Edge of Topical Psoriasis Treatment (PROPEL) surveyed Canadian dermatologists and their patients about their attitudes toward topical care.

Objectives:

To identify gaps between patients and dermatologists regarding the burden of psoriasis, the burden of treatment, and priorities for topical care to Canadian patients with psoriasis.

Methods:

Two parallel surveys explored patient attitudes toward psoriasis and their experience with topical care, as expressed by patients or as perceived by their dermatologists. A third survey, addressed to patients, included additional questions regarding treatment adherence to current topical treatment regimens.

Results:

PROPEL dermatologists underestimated the burden associated with psoriatic itch. Otherwise, they were well aligned with patients’ views, including their preference for maintaining topical care of their psoriasis over other treatment modalities, the nature of good psoriasis control, and desirable features of topical medications. Despite holding generally positive views of topical therapy, many patients self-identified as poorly adherent.

Conclusions:

Long-term adherence to psoriasis topical care remains a challenge. Formulations with improved acceptability might help patients maintain good adherence.

Keywords

psoriasis vulgaris topical care adherence treatment acceptability itch

Get full access to this article

View all access options for this article.

References

Canadian Psoriasis Guidelines Addendum Committee. Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis, 2009. J Cutan Med Surg. 2016;20:375-431.

Canadian Psoriasis Guidelines Committee. Canadian Guidelines for the Management of Plaque Psoriasis, June 2009. http://dermatology.ca/wp-content/uploads/2012/01/cdnpsoriasisguidelines.pdf. Accessed July 2017.

Albrecht

Bourcier

Ashkenas

et al . Topical psoriasis therapy in the age of biologics: evidence-based treatment recommendations. J Cutan Med Surg. 2011;15(6):309-321.

Iversen

Lange

Bissonette

et al . Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and influence of body surface area on usage. J Eur Acad Dermatol Venereol. 2017;31(7):1188-1195.

van de Kerkhof

Reich

Kavanaugh

et al . Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey. J Eur Acad Dermatol Venereol. 2015;29(10):2002-2010.

Carroll

Feldman

Camacho

Balkrishnan

. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol. 2004;151(4):895-897.

Feldman

. Disease burden and treatment adherence in psoriasis patients. Cutis. 2013;92(5):258-263.

Krejci-Manwaring

Tusa

Carroll

et al . Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211-216.

Bundy

Borthwick

McAteer

et al . Psoriasis: snapshots of the unspoken: using novel methods to explore patients’ personal models of psoriasis and the impact on well-being. Br J Dermatol. 2014;171(4):825-831.

10.

Burroni

Fassino

Torti

Visentin

. How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey. Patient Relat Outcome Meas. 2015;6:9-17.

11.

Thorneloe

Bundy

Griffiths

Ashcroft

Cordingley

. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. Br J Dermatol. 2017;176(3):667-676.

12.

Korman

Zhao

Pike

Roberts

Sullivan

Kemhus

. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Dermatol Online J. 2016;22(7).

13.

Nelson

Barker

Griffiths

Cordingley

Chew-Graham

. ‘On the surface’: a qualitative study of GPs’ and patients’ perspectives on psoriasis. BMC Fam Pract. 2013;14:158.

14.

Nelson

Chew-Graham

Griffiths

Cordingley

. Recognition of need in health care consultations: a qualitative study of people with psoriasis. Br J Dermatol. 2013;168(2):354-361.

15.

Reich

Bewley

. What is new in topical therapy for psoriasis? J Eur Acad Dermatol Venereol. 2011;25(suppl 4):15-20.

16.

Vertuani

Cvetkovska

Zauli

Virgili

Manfreddini

Bettoli

. The topical vehicle as a key factor in the management of the psoriatic patients’ therapy. G Ital Dermatol Venereol. 2013;148:679-685.

17.

Leo Pharma Inc. Canadian Product Monograph ENSTILAR^TM Calcipotriol and Betamethasone Dipropionate Aerosol Foam. Thornhill, ON: Leo Pharma Inc;2016.

18.

Lebwohl

Kavanaugh

Armstrong

Van Voorhees

. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Am J Clin Dermatol. 2015;17:87-97.

19.

Poulin

Papp

Wasel

et al . A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol. 2010;49(12):1368-1375.

20.

Armstrong

Robertson

Schupp

Lebwohl

. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013;149(10):1180-1185.

21.

Duffin

Yeung

Takeshita

et al . Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol. 2014;170:672-680.

22.

Ersser

Cowdell

Latter

Healy

. Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support. Br J Dermatol. 2010;163(5):1044-1049.

23.

Lebwohl

Bachelez

Barker

et al . Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70(5):871-881.e1-30.

24.

Heckman

Mathew

Carpenter

. Treatment burden and treatment fatigue as barriers to health. Curr Opin Psychol. 2015;5:31-36.

25.

Devaux

Castela

Archier

et al . Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(suppl 3):61-67.

26.

Halioua

Maury Le Breton

de Fontaubert

Roussel

Stalder

. Treatment refusal among patients with psoriasis. J Dermatolog Treat. 2015;26(5):396-400.

27.

Svendsen

Andersen

Hansen

Johannessen

Andersen

. Medical adherence to topical corticosteroid preparations prescribed for psoriasis: a systematic review. J Dermatol Treat. 2017;28(1):32-39.

28.

Canadian Medical Association. Dermatology profile. https://www.cma.ca/Assets/assets-library/document/en/advocacy/Dermatology-e.pdf. Accessed July 2017.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.42 MB

0.43 MB

0.47 MB